Related Experiment Video
Updated: May 10, 2025

Author Spotlight: Streamlining Rice Breeding with CRISPR/Cas for Obtaining Optimal Phenotypic and Agronomic Traits
Published on: January 3, 2025
A Novel, Multifunctional Resistant Starch-Phenol Complex with Potential for Better Glycemic Control
Huilan Zhu1,2, Mingyan Zhang1,2, Cuiping Wang1,2
1State Key Laboratory of Food Nutrition and Safety, Tianjin University of Science & Technology, Tianjin 300457, China.
A novel resistant starch complex, amylose-10-gingerol (AM-10G), shows promise for managing blood glucose. This complex inhibits starch digestion and glucose absorption, while promoting beneficial gut bacteria for improved glycemic control.
Area of Science:
- Food Science
- Nutritional Biochemistry
- Molecular Gastronomy
Background:
- Resistant starch (RS) and starch-phenol complexes offer potential for managing diet-related diseases like type 2 diabetes (T2D).
- Investigating novel functional RS is crucial for developing effective dietary strategies.
Purpose of the Study:
- To prepare and characterize a novel amylose-10-gingerol (AM-10G) complex.
- To evaluate the potential of the AM-10G complex for glycemic control.
Main Methods:
- Complex formation between amylose (AM) and 10-gingerol (10G).
- Assessing amylolysis rates and α-amylase inhibition of the AM-10G complex.
- Evaluating 10-gingerol's effect on glucose transport in Caco-2 cells and gene expression (GLUT2, SGLT1).
- Analyzing gut microbiota changes via in vitro fecal fermentation.
Main Results:
- The AM-10G complex exhibited significantly slower amylolysis compared to an AM-lauric acid complex.
- α-amylase activity was substantially inhibited by the AM-10G complex during digestion.
- 10-gingerol reduced glucose transport by 60% and downregulated GLUT2 and SGLT1 mRNA expression.
- AM-10G complex fermentation promoted beneficial gut bacteria (Lachnospiraceae_NK4A136_group, Lachnospiraceae_UCG_004).
Conclusions:
- The AM-10G complex demonstrates potential for glycemic control.
- Inhibitory effects on amylolysis and glucose transporters contribute to its efficacy.
- Modulation of gut microbiota plays a role in its beneficial glycemic effects.
More Related Videos
14:39Semi-Targeted Ultra-High-Performance Chromatography Coupled to Mass Spectrometry Analysis of Phenolic Metabolites in Plasma of Elderly Adults
Published on: April 22, 2022
05:22Transverse Sectioning of Mature Rice Oryza sativa L. Kernels for Scanning Electron Microscopy Imaging Using Pipette Tips as Immobilization Support
Published on: January 25, 2022
Related Concept Videos
Oral Hypoglycemic Agents: α-Glucosidase Inhibitors
Acarbose and miglitol are...
Glucagon-like Receptor Agonists
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
Oral Hypoglycemic Agents: Glinides
Dipeptidyl Peptidase 4 Inhibitors
Introduction to Carbohydrates
Oral Hypoglycemic Agents: Biguanides and Glitazones